» Articles » PMID: 37716411

Microvascular Smooth Muscle Cells Exhibit Divergent Phenotypic Switching Responses to Platelet-derived Growth Factor and Insulin-like Growth Factor 1

Overview
Journal Microvasc Res
Date 2023 Sep 16
PMID 37716411
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Vascular smooth muscle cell (VSMC) phenotypic switching is critical for normal vessel formation, vascular stability, and healthy brain aging. Phenotypic switching is regulated by mediators including platelet derived growth factor (PDGF)-BB, insulin-like growth factor (IGF-1), as well as transforming growth factor-β (TGF-β) and endothelin-1 (ET-1), but much about the role of these factors in microvascular VSMCs remains unclear.

Methods: We used primary rat microvascular VSMCs to explore PDGF-BB- and IGF-1-induced phenotypic switching.

Results: PDGF-BB induced an early proliferative response, followed by formation of polarized leader cells and rapid, directionally coordinated migration. In contrast, IGF-1 induced cell hypertrophy, and only a small degree of migration by unpolarized cells. TGF-β and ET-1 selectively inhibit PDGF-BB-induced VSMC migration primarily by repressing migratory polarization and formation of leader cells. Contractile genes were downregulated by both growth factors, while other genes were differentially regulated by PDGF-BB and IGF-1.

Conclusions: These studies indicate that PDGF-BB and IGF-1 stimulate different types of microvascular VSMC phenotypic switching characterized by different modes of cell migration. Our studies are consistent with a chronic vasoprotective role for IGF-1 in VSMCs in the microvasculature while PDGF is more involved in VSMC proliferation and migration in response to acute activities such as neovascularization. Better understanding of the nuances of the phenotypic switching induced by these growth factors is important for our understanding of a variety of microvascular diseases.

Citing Articles

Pomegranate as a natural remedy for gastric ulcers prevention: a review of its gastroprotective mechanisms and pharmacological benefits.

Zamanian M, Gardanova Z, Hjazi A, Uthirapathy S, Jyothi S, Shit D Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39888366 DOI: 10.1007/s00210-025-03822-8.


The vasoprotective role of IGF-1 signaling in the cerebral microcirculation: prevention of cerebral microhemorrhages in aging.

Stankovics L, Ungvari A, Fekete M, Nyul-Toth A, Mukli P, Patai R Geroscience. 2024; 47(1):445-455.

PMID: 39271571 PMC: 11872839. DOI: 10.1007/s11357-024-01343-5.


IGF1R deficiency in vascular smooth muscle cells impairs myogenic autoregulation and cognition in mice.

Miller L, Bickel M, Tarantini S, Runion M, Matacchiera Z, Vance M Front Aging Neurosci. 2024; 16:1320808.

PMID: 38425784 PMC: 10902040. DOI: 10.3389/fnagi.2024.1320808.


Vascular smooth muscle cell-specific Igf1r deficiency exacerbates the development of hypertension-induced cerebral microhemorrhages and gait defects.

Miller L, Bickel M, Vance M, Vaden H, Nagykaldi D, Nyul-Toth A Geroscience. 2024; 46(3):3481-3501.

PMID: 38388918 PMC: 11009188. DOI: 10.1007/s11357-024-01090-7.

References
1.
von der Thusen J, Borensztajn K, Moimas S, van Heiningen S, Teeling P, Van Berkel T . IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype. Am J Pathol. 2011; 178(2):924-34. PMC: 3069834. DOI: 10.1016/j.ajpath.2010.10.007. View

2.
Abraham S, Kogata N, Fassler R, Adams R . Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability. Circ Res. 2008; 102(5):562-70. DOI: 10.1161/CIRCRESAHA.107.167908. View

3.
Petrie R, Doyle A, Yamada K . Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol. 2009; 10(8):538-49. PMC: 2752299. DOI: 10.1038/nrm2729. View

4.
Deng L, Huang L, Sun Y, Heath J, Wu H, Chen Y . Inhibition of FOXO1/3 promotes vascular calcification. Arterioscler Thromb Vasc Biol. 2014; 35(1):175-83. PMC: 4270841. DOI: 10.1161/ATVBAHA.114.304786. View

5.
Rabinovitch M . Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest. 2008; 118(7):2372-9. PMC: 2439479. DOI: 10.1172/JCI33452. View